Fundraising Fox

Ori Biotech

4 known investors

oribiotech.com ↗

Ori Biotech builds IRO, a flexible and scalable manufacturing platform for developing cell and gene therapies. It serves scientists and therapy developers in the biotech and life sciences industry, aiming to reduce batch failures, increase throughput, and lower costs.

BiotechHardwareHealthtech

Investors · 4

Amadeus Capital PartnersLondon · $50K – $12.7M
Kindred CapitalLondon
Novalis LifeSciencesPortsmouth
Puhua CapitalreportedHangzhou · $1.4M – $112M

In the news

Ori Biotech Raises €88M to Automate Cell Therapy Manufacturepharma-industry-review.com · Jan 2022Ori Biotech raises £75m for cell and gene therapy platformbusinesscloud.co.uk · Jan 2022Ori Biotech Raises Over USD100M in Series B Fundingfinsmes.com · Jan 2022Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech | Fierce Pharmafiercepharma.com · Jan 2022Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform | Oribiotech Ltdoribiotech.com · Jan 2022Ori Biotech Raises $30 Million in Financinggenengnews.com · Oct 2020

Frequently asked questions

What does Ori Biotech do?
Ori Biotech builds IRO, a flexible and scalable manufacturing platform for developing cell and gene therapies. It serves scientists and therapy developers in the biotech and life sciences industry, aiming to reduce batch failures, increase throughput, and lower costs.
Who are Ori Biotech's investors?
Ori Biotech's investors include Amadeus Capital Partners, Kindred Capital, Novalis LifeSciences, Puhua Capital.